Background The causes, optimal treatments, and medical/psychosocial sequelae of breast
cancer in men are poorly understood. Design A systematic review of the English language …

Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical
management is based on results obtained from randomized trials conducted in women …

Breast cancer is the most common cancer among women, accounting for about 30% of all
cancers. In contrast, breast cancer is a rare disease in men, accounting for less than 1% of …

Background. The purpose was to analyze the behavior of male breast cancer. Methods. Fifty-
eight male breast cancer patients were treated at the HUCH during 1981–2006. Data on risk …

Although rare, male breast cancer (MBC) remains a substantial cause for morbidity and
mortality in men. Based on age frequency distribution, age-specific incidence rate pattern …

Currently, there is a paucity of highly specific and sensitive markers to identify breast
carcinoma in male patients. Immunohistochemical stains commonly used for unmasking …

Background Overall, HER2-amplified female breast cancer (FBC) is associated with a high
grade, an aggressive phenotype and a poor prognosis. In male breast cancer (MBC) …